diclofenac has been researched along with guaifenesin in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 9 (81.82) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Elkady, EF | 1 |
Abdelaleem, EA; Abdelkawy, M; Ali, NW; Hegazy, MA | 1 |
Jiang, JG; Song, GS; Zhang, XR; Zhang, YH | 1 |
Allen, A; Lennard, TW; Rhodes, M | 1 |
Holm, L; Jansson, EA; Lundberg, JO; Patzak, A; Petersson, J; Phillipson, M | 1 |
Amagase, K; Satoh, H; Takeuchi, K | 1 |
Cetin, N; Duzgun, A; Gencoglu, S; Gul, MA; Kiran, A; Kurtoglu, IZ; Kuyrukluyildiz, U; Nalkiran, HS; Suleyman, B; Suleyman, H; Yarali, O | 1 |
Bhatia, M; Devi, R | 1 |
1 review(s) available for diclofenac and guaifenesin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for diclofenac and guaifenesin
Article | Year |
---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Simultaneous determination of diclofenac potassium and methocarbamol in ternary mixture with guaifenesin by reversed phase liquid chromatography.
Topics: Chromatography, Liquid; Diclofenac; Guaifenesin; Methocarbamol; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet | 2010 |
Simultaneous determination of methocarbamol and ibuprofen or diclofenac potassium using mean centering of the ratio spectra method.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calibration; Chromatography, High Pressure Liquid; Computing Methodologies; Diclofenac; Drug Combinations; Drug Stability; Expectorants; Guaifenesin; Ibuprofen; Limit of Detection; Methocarbamol; Muscle Relaxants, Central; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets; Technology, Pharmaceutical | 2012 |
[Rapid identification 15 effective components of anti common cold medicine with MRM by LC-MS/MS].
Topics: Acetaminophen; Acetanilides; Amantadine; Aminopyrine; Anti-Inflammatory Agents, Non-Steroidal; Antipyretics; Antipyrine; Caffeine; Chlorpheniramine; Chromatography, Liquid; Diclofenac; Diphenhydramine; Drug Contamination; Drug Stability; Ephedrine; Guaifenesin; Promethazine; Pseudoephedrine; Reproducibility of Results; Salicylates; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2013 |
Mucus glycoprotein biosynthesis in the human gall bladder: inhibition by aspirin.
Topics: Aspirin; Depression, Chemical; Diclofenac; Gallbladder; Glucosamine; Glycoproteins; Humans; In Vitro Techniques; Mucus | 1992 |
Dietary nitrate increases gastric mucosal blood flow and mucosal defense.
Topics: Administration, Oral; Animals; Blood Pressure; Diclofenac; Gastric Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mucus; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Permeability; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Stomach; Taurocholic Acid; Vascular Resistance | 2007 |
Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dose-Response Relationship, Drug; Gastric Mucins; Gastrointestinal Agents; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Misoprostol; Mucus; Omeprazole; Protective Agents; Proton Pump Inhibitors; Quinolones; Ranitidine; Rats; Rats, Wistar; Sus scrofa; Triazines | 2014 |
Investigation of mucus obtained from different fish species on the acute pain induced with scalpel incision in paw of rats.
Topics: Acute Pain; Analgesics; Animals; Antioxidants; Cyclooxygenase 2; Diclofenac; Fishes; Gene Expression; Male; Mucus; Oxidants; Pain, Postoperative; Rats, Wistar | 2016 |
Thiol functionalization of flaxseed mucilage: Preparation, characterization and evaluation as mucoadhesive polymer.
Topics: Adhesiveness; Calorimetry, Differential Scanning; Diclofenac; Drug Liberation; Flax; Magnetic Resonance Spectroscopy; Mucus; Plant Mucilage; Polymers; Spectroscopy, Fourier Transform Infrared; Sulfhydryl Compounds; X-Ray Diffraction | 2019 |